Merck
CN

Paroxetine hydrochloride.

Profiles of drug substances, excipients, and related methodology (2013-05-15)
David Germann, George Ma, Feixue Han, Anna Tikhomirova
摘要

Paroxetine hydrochloride (3S-trans)-3-[(1,3-benzodioxol-5-yloxy)methyl]-4-(4-fluorophenyl)-piperidine hydrochloride (or (-)-(3S,4R)-(4-(p-fluorophenyl)-3-[[3,4-(methylenedioxy)-phenoxy]methyl]piperidine hydrochloride), a phenylpiperidine derivative, is a selective serotonin reuptake inhibitor. Paroxetine is indicated for the treatment of depression, generalized anxiety disorder, obsessive-compulsive disorder, panic disorder, posttraumatic stress disorder, and social anxiety disorder. The physicochemical properties, spectroscopic data (1D and 2D NMR, UV, FT-IR, MS, PXRD), stability, methods of preparation and chromatographic methods of analysis of pharmaceutical, and biological samples of paroxetine are documented in this review. Pharmacokinetics, metabolism, and pharmacological effects are also discussed.

材料
货号
品牌
产品描述

Sigma-Aldrich
帕罗西汀 盐酸盐 半水合物, ≥98% (HPLC), powder
Supelco
Paroxetine maleate solution, 1.0 mg/mL in methanol (as free base), ampule of 1 mL, certified reference material, Cerilliant®
Sigma-Aldrich
帕罗西汀 马来酸盐, ≥98% (HPLC), solid
帕罗西汀 盐酸盐 半水合物, European Pharmacopoeia (EP) Reference Standard
帕罗西汀, European Pharmacopoeia (EP) Reference Standard